Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
104 participants
INTERVENTIONAL
2023-02-06
2024-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automated Inhaler Monitoring for Asthma Medication Usage
NCT06825871
Monitoring Asthma Treatment Using Exhaled Nitric Oxide
NCT00562991
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069
A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449
NCT03766399
Feasibility of a Smartphone Application for Asthma Self-management
NCT05572177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
Standard care
Health service standard care will be continued
aflo™ digital respiratory management platform with standard care
The new aflo™ digital respiratory management platform will provide automated inhaler technique direction, with real time quantitative personalised feedback on inhaler technique and timing.
aflo™ digital respiratory management platform
medical device, user app, clinician portal, data analytics hub
Standard care
Health service standard care will be continued
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aflo™ digital respiratory management platform
medical device, user app, clinician portal, data analytics hub
Standard care
Health service standard care will be continued
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to WiFi and a smart phone (Android or apple phone with latest version -2) and knowledge of / carer support with using a smartphone.
* For children (parent/ carer must register and provide smart phone access)
* Aged \> 5 years (with carer/ parental consent if \< 17 years old)
* Smart phone user/ willing to use (or parent/ carer) and have access to and knowledge of working a smart phone and WIFI / 4G
* Currently prescribed an inhaled reliever +/- preventer medication via pressurised
* Metered Dose Inhaler (MDI) short acting beta2 agonist (SABA), inhaled corticosteroid (ICS) ICS / long acting beta2 agonist (LABA) MDI +/- spacer
* Adherence/ symptom control issues with medication (as identified by excess use of SABA/ healthcare personnel visits/ calls/ emergency department visit/ hospital admission
* Those who understand written and spoken English
Exclusion Criteria
* Other major respiratory illness or significant concurrent disease that might prevent completion of the study
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northern Ireland Clinical Research Service
UNKNOWN
University of Ulster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Intervention Studies Unit
Coleraine, N.Ireland, United Kingdom
Health Hub Professionals
Londonderry, N.Ireland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22.WM.0278
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.